244 related articles for article (PubMed ID: 4197258)
1. A double-blind comparison of AL-1021 and chlorpromazine in hospitalized schizophrenics.
Gendron JL; Zimmermann RL; Schiele BC
Curr Ther Res Clin Exp; 1973 Jun; 15(6):333-6. PubMed ID: 4197258
[No Abstract] [Full Text] [Related]
2. A controlled double-blind comparison between loxapine succinate and chlorpromazine in acute newly hospitalized schizophrenic patients.
Shopsin B; Pearson E; Gershon S; Collins P
Curr Ther Res Clin Exp; 1972 Nov; 14(11):739-48. PubMed ID: 4629112
[No Abstract] [Full Text] [Related]
3. Lenperone: a controlled evaluation in chronic schizophrenic patients.
Mielke DH; Gallant DM; Kessler C; Roniger JJ
Curr Ther Res Clin Exp; 1975 Nov; 18(5):636-40. PubMed ID: 812640
[No Abstract] [Full Text] [Related]
4. A pilot study on the use of AL-1021 in the treatment of acute schizophrenics.
Gendron JL; Schiele BC
Curr Ther Res Clin Exp; 1971 Mar; 13(3):169-73. PubMed ID: 4998288
[No Abstract] [Full Text] [Related]
5. A double-blind comparison of pimozide and chlorpromazine in the maintenance care of chronic schizophrenic outpatients.
Kolivakis T; Azim H; Kingstone E
Curr Ther Res Clin Exp; 1974 Sep; 16(9):998-1004. PubMed ID: 4214674
[No Abstract] [Full Text] [Related]
6. Double blind study of clopenthixol and chlorpromazine in acute hospitalized schizophrenics.
Kingstone E; Kolivakis T; Kossatz I
Int Z Klin Pharmakol Ther Toxikol; 1970 Jan; 3(1):41-5. PubMed ID: 4909377
[No Abstract] [Full Text] [Related]
7. A pilot study of CI-601 in chronic schizophrenics.
Sugerman AA; Herrmann J; O'Hara M
Curr Ther Res Clin Exp; 1968 Oct; 10(10):529-32. PubMed ID: 4971468
[No Abstract] [Full Text] [Related]
8. A double-blind evaluation of metiapine in hospitalized acute schizophrenics.
Kramer M; Roth T; Goldstein S; Ryan MS; Blackwell B
Curr Ther Res Clin Exp; 1975 Dec; 18(6):839-48. PubMed ID: 2450
[No Abstract] [Full Text] [Related]
9. A double blind comparison of thiothixene and a trifluoperazine/chlorpromazine composite in the treatment of chronic schizophrenia.
Knight RG; Harrison A
N Z Med J; 1979 Apr; 89(634):302-4. PubMed ID: 377155
[TBL] [Abstract][Full Text] [Related]
10. An early clinical trial of lenperone (AHR 2277), a butyrophenone, in chronic schizophrenia.
Simpson GM; Varga V
Curr Ther Res Clin Exp; 1974 May; 16(5):477-82. PubMed ID: 4209063
[No Abstract] [Full Text] [Related]
11. Loxapine: a double-blind comparison with chlorpromazine in acute schizophrenic patients.
Steinbook RM; Goldstein BJ; Brauzer B; Moreno SS; Jacobson AF
Curr Ther Res Clin Exp; 1973 Jan; 15(1):1-7. PubMed ID: 4631378
[No Abstract] [Full Text] [Related]
12. A double blind controlled study of ECT vs chlorpromazine in schizophrenia.
Bagadia VN; Abhyankar RR; Doshi J; Pradhan PV; Shah LP
J Assoc Physicians India; 1983 Oct; 31(10):637-40. PubMed ID: 6671932
[No Abstract] [Full Text] [Related]
13. A double-blind comparison of the therapeutic efficacy of mesoridazine versus chlorpromazine.
Freeman H; Oktem MR; Oktem N
Curr Ther Res Clin Exp; 1969 May; 11(5):263-70. PubMed ID: 4977397
[No Abstract] [Full Text] [Related]
14. Pilot study on the use of AL-1021 in the treatment of chronic schizophrenia.
Angus JW; Go SH; Simpson GM
Curr Ther Res Clin Exp; 1969 Dec; 11(12):779-83. PubMed ID: 4984043
[No Abstract] [Full Text] [Related]
15. A double-blind comparison of mesoridazine and chlorpromazine in chronic schizophrenics.
Freeman H
Dis Nerv Syst; 1973; 34(6):289-93. PubMed ID: 4782285
[No Abstract] [Full Text] [Related]
16. Comparative study of TPS-23, chlorpromazine and placebo in chronic schizophrenic patients.
Tetreault L; Bordeleau JM; Gauthier R; Vulpe M; Lapointe L
Dis Nerv Syst; 1969 Feb; 30(2):Suppl:74-84. PubMed ID: 4886994
[No Abstract] [Full Text] [Related]
17. A double blind study of clomacran.
Lampe WT
Curr Ther Res Clin Exp; 1969 May; 11(5):300-6. PubMed ID: 4977403
[No Abstract] [Full Text] [Related]
18. A pilot study of AL-1021 in chronic schizophrenic patients.
Sugerman AA
Curr Ther Res Clin Exp; 1969 Dec; 11(12):775-8. PubMed ID: 4984042
[No Abstract] [Full Text] [Related]
19. Controlled comparison of SK&F 14336 and chlorpromazine in newly admitted schizophrenics.
Overall JE; Hollister LE; Prusmack JJ; Shelton J; Pokorny A
J Clin Pharmacol J New Drugs; 1969; 9(5):328-38. PubMed ID: 4899114
[No Abstract] [Full Text] [Related]
20. Further studies of the butyrophenone, CI-601, in chronic schizophrenic patients.
Edwards JG; Simpson GM
Curr Ther Res Clin Exp; 1968 Oct; 10(10):520-8. PubMed ID: 4971467
[No Abstract] [Full Text] [Related]
[Next] [New Search]
